The VSL#3 probiotic formula induces mucin gene expression and secretion in colonic epithelial cells
Top Cited Papers
- 1 January 2007
- journal article
- Published by American Physiological Society in American Journal of Physiology-Gastrointestinal and Liver Physiology
- Vol. 292 (1) , G315-G322
- https://doi.org/10.1152/ajpgi.00265.2006
Abstract
Several studies have stressed the importance of the microbiota in the maintenance of the gastrointestinal epithelium. Administration of probiotic bacteria, supplements composed of microbiota constituents, was previously shown to diminish symptoms in patients suffering from inflammatory bowel diseases. This raises the possibility that probiotics may play an active role in enhancing the intestinal barrier at the mucosal surface. In this study, we investigated whether the clinically tested VSL#3 probiotic formula and/or its secreted components can augment the protective mucus layer in vivo and in vitro. For in vivo studies, Wistar rats were orally administered the probiotic mixture VSL#3 on a daily basis for seven days. After treatment, basal luminal mucin content increased by 60%. In addition, we exposed isolated rat colonic loops to the VSL#3 probiotic formula, which significantly stimulated colonic mucin (MUC) secretion and MUC2 gene expression; however, MUC1 and MUC3 gene expression were only slightly elevated. The effect of the VSL#3 mucin secretagogue was also tested in vitro by use of LS 174T colonic epithelial cells. In contrast to the animal studies, cultured cells incubated with VSL#3 bacteria did not exhibit increased mucin secretion. However, the bacterial secreted products contained in the conditioned media stimulated a remarkable mucin secretion effect. Among the three bacterial groups ( Lactobacilli, Bifidobacteria, and Streptococci) contained in VSL#3, the Lactobacillus species were the strongest potentiator of mucin secretion in vitro. A preliminary characterization of the putative mucin secretagogue suggested that it was a heat-resistant soluble compound, which is not sensitive to protease and DNase treatment. These findings contribute to a better understanding of the complex and beneficial interaction between colonic epithelial cells and intestinal bacteria.Keywords
This publication has 47 references indexed in Scilit:
- Mucin Macromolecules in Normal, Adenomatous, and Carcinomatous Colon: Evidence for the NeotransformationMacromolecular Bioscience, 2004
- Probiotics for treating infectious diarrhoeaPublished by Wiley ,2003
- Trefoil factors: initiators of mucosal healingNature Reviews Molecular Cell Biology, 2003
- mRNA of MUC2 is stimulated by IL‐4, IL‐13 or TNF‐α through a mitogen‐activated protein kinase pathway in human colon cancer cellsImmunology & Cell Biology, 2003
- Induction of MUC2 and MUC5AC Mucins by Factors of the Epidermal Growth Factor (EGF) Family Is Mediated by EGF Receptor/Ras/Raf/Extracellular Signal-regulated Kinase Cascade and Sp1*Journal of Biological Chemistry, 2002
- Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2−ΔΔCT MethodMethods, 2001
- Interaction between bacterial peptides, neutrophils and goblet cells: a possible mechanism for neutrophil recruitment and goblet cell depletion in colitisClinical Science, 2001
- Mucin secretion is modulated by luminal factors in the isolated vascularly perfused rat colonGut, 2000
- Interaction of LS174T human colon cancer cell mucins with Entamoeba histolytica: An in vitro model for colonic diseaseGastroenterology, 1996
- Histochemical, Lectin-Histochemical and Morphometrical Characteristics of Intestinal Goblet Cells of Germfree and Conventional Mice.Experimental Animals, 1996